Tonix Pharmaceuticals Holding (TNXP) Gross Profit (2023 - 2026)

Tonix Pharmaceuticals Holding has reported Gross Profit for 4 years, with the latest figure at $12.8 million in Q2 2026.

• On a quarterly basis, Gross Profit rose 1107.93% year-over-year to $12.8 million in Q2 2026; TTM through Jun 2026 was $24.4 million, a 747.67% increase from a year earlier, with the FY2025 full-year figure at $6.5 million, up 177.67% from the prior year.
• Gross Profit was $12.8 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $5.3 million in the prior quarter.
• The five-year high for Gross Profit was $12.8 million in Q2 2026, with the low at -$1.3 million in Q2 2025.
• Average Gross Profit over 4 years is $2.5 million, with a median of $1.4 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2026: Gross Profit fell 21.55% in 2024, then jumped 1107.93% in 2026.
• Over 4 years, Gross Profit stood at $1.4 million in 2023, then dropped by 0.92% to $1.4 million in 2024, then surged by 209.65% to $4.3 million in 2025, then soared by 196.42% to $12.8 million in 2026.
• The last three Gross Profit figures came in at $12.8 million (Q2 2026), $5.3 million (Q1 2026), and $4.3 million (Q4 2025), per Business Quant data.